| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatocytes | 115 | 2024 | 1247 | 12.830 |
Why?
|
| Liver | 120 | 2024 | 7578 | 5.100 |
Why?
|
| Cell Culture Techniques | 45 | 2019 | 1667 | 3.800 |
Why?
|
| Burns | 51 | 2025 | 1901 | 3.780 |
Why?
|
| Tissue Engineering | 39 | 2022 | 1893 | 3.750 |
Why?
|
| Electroporation | 9 | 2018 | 239 | 3.450 |
Why?
|
| Microfluidic Analytical Techniques | 23 | 2019 | 820 | 3.130 |
Why?
|
| Elastin | 12 | 2022 | 299 | 2.930 |
Why?
|
| Rats | 191 | 2024 | 23782 | 2.760 |
Why?
|
| Rats, Inbred Lew | 68 | 2019 | 1163 | 2.720 |
Why?
|
| Embryonic Stem Cells | 17 | 2011 | 1250 | 2.670 |
Why?
|
| Fatty Liver | 15 | 2024 | 810 | 2.600 |
Why?
|
| Perfusion | 34 | 2022 | 1401 | 2.360 |
Why?
|
| Coculture Techniques | 34 | 2016 | 1344 | 2.270 |
Why?
|
| Liver, Artificial | 19 | 2010 | 56 | 2.260 |
Why?
|
| Liver Transplantation | 30 | 2020 | 2401 | 2.200 |
Why?
|
| Models, Biological | 49 | 2023 | 9497 | 2.140 |
Why?
|
| Microfluidics | 16 | 2023 | 672 | 2.070 |
Why?
|
| Mesenchymal Stem Cells | 20 | 2019 | 1673 | 2.010 |
Why?
|
| Organ Preservation | 15 | 2020 | 393 | 1.850 |
Why?
|
| Retroviridae | 15 | 2008 | 846 | 1.810 |
Why?
|
| Animals | 363 | 2024 | 169285 | 1.790 |
Why?
|
| Cells, Cultured | 110 | 2024 | 19025 | 1.690 |
Why?
|
| Extracellular Matrix | 19 | 2024 | 1738 | 1.600 |
Why?
|
| Alginates | 6 | 2015 | 250 | 1.460 |
Why?
|
| Collagen | 29 | 2020 | 2645 | 1.430 |
Why?
|
| Rats, Sprague-Dawley | 60 | 2024 | 8142 | 1.420 |
Why?
|
| Wound Healing | 24 | 2024 | 2815 | 1.370 |
Why?
|
| Liver Regeneration | 4 | 2016 | 214 | 1.300 |
Why?
|
| Cell Communication | 11 | 2016 | 1660 | 1.300 |
Why?
|
| Disinfection | 4 | 2020 | 207 | 1.280 |
Why?
|
| Cell Differentiation | 31 | 2024 | 11677 | 1.250 |
Why?
|
| Liver Failure | 9 | 2012 | 252 | 1.230 |
Why?
|
| Rejuvenation | 3 | 2023 | 110 | 1.210 |
Why?
|
| Cell Survival | 41 | 2024 | 5789 | 1.210 |
Why?
|
| Cryopreservation | 21 | 2024 | 733 | 1.200 |
Why?
|
| Biomedical Engineering | 7 | 2014 | 286 | 1.200 |
Why?
|
| Electric Stimulation Therapy | 4 | 2024 | 635 | 1.140 |
Why?
|
| Biopolymers | 2 | 2020 | 183 | 1.140 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2022 | 1124 | 1.130 |
Why?
|
| Tissue Scaffolds | 10 | 2024 | 951 | 1.130 |
Why?
|
| Energy Metabolism | 15 | 2017 | 2907 | 1.120 |
Why?
|
| Liver Failure, Acute | 6 | 2012 | 182 | 1.110 |
Why?
|
| Fibroblast Growth Factor 7 | 4 | 2020 | 59 | 1.100 |
Why?
|
| Wound Infection | 4 | 2020 | 243 | 1.080 |
Why?
|
| Gap Junctions | 4 | 2020 | 230 | 1.070 |
Why?
|
| Cicatrix, Hypertrophic | 5 | 2016 | 80 | 0.990 |
Why?
|
| Oxygen | 25 | 2019 | 4270 | 0.980 |
Why?
|
| Urea | 22 | 2019 | 448 | 0.970 |
Why?
|
| Photolysis | 11 | 1998 | 94 | 0.930 |
Why?
|
| Biotechnology | 10 | 2008 | 283 | 0.890 |
Why?
|
| Liver Diseases | 9 | 2019 | 1305 | 0.880 |
Why?
|
| Reperfusion Injury | 6 | 2014 | 1039 | 0.870 |
Why?
|
| Nanotechnology | 6 | 2021 | 714 | 0.860 |
Why?
|
| Cell Line | 42 | 2023 | 15602 | 0.850 |
Why?
|
| Oligopeptides | 3 | 2018 | 1194 | 0.840 |
Why?
|
| Pharmaceutical Preparations | 7 | 2022 | 1088 | 0.840 |
Why?
|
| Amino Acids | 15 | 2013 | 1716 | 0.830 |
Why?
|
| Mice | 122 | 2023 | 82049 | 0.830 |
Why?
|
| Dimethylpolysiloxanes | 5 | 2023 | 143 | 0.820 |
Why?
|
| Temperature | 14 | 2021 | 2234 | 0.820 |
Why?
|
| Cytochrome P-450 Enzyme System | 8 | 2022 | 423 | 0.820 |
Why?
|
| Cell Proliferation | 18 | 2024 | 10478 | 0.800 |
Why?
|
| Bioreactors | 14 | 2011 | 246 | 0.800 |
Why?
|
| Heat-Shock Response | 4 | 2009 | 179 | 0.800 |
Why?
|
| Albumins | 22 | 2017 | 577 | 0.800 |
Why?
|
| Tissue Preservation | 3 | 2021 | 173 | 0.790 |
Why?
|
| Transfection | 10 | 2017 | 5756 | 0.780 |
Why?
|
| Lab-On-A-Chip Devices | 8 | 2023 | 445 | 0.770 |
Why?
|
| Blood Physiological Phenomena | 1 | 2021 | 53 | 0.770 |
Why?
|
| Skin | 16 | 2024 | 4505 | 0.760 |
Why?
|
| Endothelial Cells | 10 | 2023 | 3589 | 0.760 |
Why?
|
| Bone Marrow Cells | 8 | 2014 | 2414 | 0.750 |
Why?
|
| Warm Ischemia | 8 | 2019 | 59 | 0.750 |
Why?
|
| Erythropoietin | 3 | 2016 | 718 | 0.740 |
Why?
|
| Culture Media | 14 | 2008 | 898 | 0.740 |
Why?
|
| Nanoparticles | 5 | 2024 | 1986 | 0.740 |
Why?
|
| Immunotoxins | 7 | 1997 | 175 | 0.740 |
Why?
|
| Disease Models, Animal | 33 | 2024 | 18349 | 0.720 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 6 | 2015 | 507 | 0.720 |
Why?
|
| Fibroblasts | 16 | 2016 | 4178 | 0.720 |
Why?
|
| Cell Separation | 10 | 2016 | 1728 | 0.710 |
Why?
|
| Regeneration | 7 | 2017 | 1524 | 0.700 |
Why?
|
| Pseudomonas Infections | 5 | 2020 | 623 | 0.690 |
Why?
|
| 3T3 Cells | 24 | 2010 | 1084 | 0.690 |
Why?
|
| Glucose | 18 | 2020 | 4352 | 0.690 |
Why?
|
| Gene Expression Profiling | 18 | 2014 | 9540 | 0.680 |
Why?
|
| Antibodies, Monoclonal | 33 | 2021 | 9262 | 0.670 |
Why?
|
| Organ Culture Techniques | 4 | 2015 | 796 | 0.660 |
Why?
|
| Liver Circulation | 5 | 2011 | 159 | 0.660 |
Why?
|
| Stromal Cells | 7 | 2014 | 1337 | 0.660 |
Why?
|
| Inflammation | 19 | 2023 | 10873 | 0.650 |
Why?
|
| T-Lymphocytes | 10 | 2023 | 10266 | 0.650 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 2 | 2009 | 23 | 0.650 |
Why?
|
| Peptides | 10 | 2021 | 4354 | 0.650 |
Why?
|
| Drug Evaluation, Preclinical | 8 | 2020 | 1339 | 0.650 |
Why?
|
| Pseudomonas aeruginosa | 8 | 2020 | 1276 | 0.650 |
Why?
|
| Green Fluorescent Proteins | 9 | 2014 | 2065 | 0.640 |
Why?
|
| Plasma | 5 | 2004 | 585 | 0.640 |
Why?
|
| Paracrine Communication | 4 | 2011 | 279 | 0.640 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2015 | 4355 | 0.630 |
Why?
|
| Immunomodulation | 2 | 2015 | 549 | 0.630 |
Why?
|
| Culture Media, Conditioned | 8 | 2014 | 521 | 0.630 |
Why?
|
| Blood | 1 | 2021 | 599 | 0.630 |
Why?
|
| Cold Temperature | 10 | 2024 | 791 | 0.610 |
Why?
|
| Reperfusion | 2 | 2010 | 266 | 0.610 |
Why?
|
| Keratinocytes | 8 | 2018 | 876 | 0.600 |
Why?
|
| Interleukin-1 | 6 | 2005 | 1252 | 0.590 |
Why?
|
| Spinal Cord Injuries | 5 | 2022 | 928 | 0.590 |
Why?
|
| Specimen Handling | 2 | 2021 | 707 | 0.590 |
Why?
|
| Cryoprotective Agents | 6 | 2022 | 128 | 0.590 |
Why?
|
| Microspheres | 6 | 2016 | 788 | 0.590 |
Why?
|
| Tissue Donors | 9 | 2024 | 2381 | 0.580 |
Why?
|
| Capsules | 2 | 2017 | 193 | 0.580 |
Why?
|
| Dinoprostone | 3 | 2015 | 597 | 0.580 |
Why?
|
| Antigen-Antibody Complex | 10 | 1999 | 513 | 0.580 |
Why?
|
| Stem Cells | 7 | 2014 | 3538 | 0.570 |
Why?
|
| Flavanones | 4 | 2011 | 75 | 0.570 |
Why?
|
| Taste Perception | 1 | 2017 | 38 | 0.560 |
Why?
|
| Skin Aging | 1 | 2018 | 141 | 0.560 |
Why?
|
| Gold | 2 | 2012 | 488 | 0.560 |
Why?
|
| Oxygen Consumption | 8 | 2010 | 1880 | 0.560 |
Why?
|
| Metabolic Clearance Rate | 7 | 2009 | 363 | 0.560 |
Why?
|
| Toxicity Tests | 2 | 2020 | 114 | 0.550 |
Why?
|
| Porphyrins | 7 | 1996 | 352 | 0.550 |
Why?
|
| Insulin | 20 | 2019 | 6610 | 0.540 |
Why?
|
| Microelectrodes | 2 | 2008 | 305 | 0.540 |
Why?
|
| Metabolism | 4 | 2007 | 193 | 0.530 |
Why?
|
| Biosensing Techniques | 4 | 2017 | 662 | 0.520 |
Why?
|
| Lipopolysaccharides | 7 | 2025 | 2222 | 0.510 |
Why?
|
| Serum Albumin | 11 | 2014 | 677 | 0.510 |
Why?
|
| Polylysine | 3 | 2006 | 130 | 0.500 |
Why?
|
| Kinetics | 31 | 2009 | 6330 | 0.500 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 254 | 0.500 |
Why?
|
| DNA | 11 | 2015 | 7213 | 0.500 |
Why?
|
| Biocompatible Materials | 9 | 2024 | 1703 | 0.500 |
Why?
|
| Culture Media, Serum-Free | 5 | 2010 | 148 | 0.500 |
Why?
|
| Equipment Design | 18 | 2020 | 3522 | 0.500 |
Why?
|
| Serum Albumin, Bovine | 11 | 1999 | 320 | 0.500 |
Why?
|
| Cell Lineage | 7 | 2011 | 2575 | 0.500 |
Why?
|
| Longevity | 1 | 2023 | 1077 | 0.490 |
Why?
|
| Gastric Bypass | 4 | 2017 | 824 | 0.490 |
Why?
|
| Appetite | 1 | 2017 | 247 | 0.490 |
Why?
|
| Ischemia | 5 | 2019 | 1900 | 0.490 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2017 | 3740 | 0.490 |
Why?
|
| Mitochondria, Liver | 3 | 2008 | 190 | 0.490 |
Why?
|
| Sepsis | 5 | 2025 | 2608 | 0.480 |
Why?
|
| Nitrogen | 4 | 2016 | 345 | 0.480 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2014 | 22 | 0.480 |
Why?
|
| Skin Irritancy Tests | 1 | 2014 | 4 | 0.480 |
Why?
|
| Transduction, Genetic | 6 | 2006 | 899 | 0.480 |
Why?
|
| Adenosine Triphosphate | 9 | 2020 | 2004 | 0.480 |
Why?
|
| Electrodes | 3 | 2017 | 617 | 0.480 |
Why?
|
| Interleukin-6 | 11 | 2017 | 3229 | 0.480 |
Why?
|
| Hepacivirus | 4 | 2016 | 1344 | 0.470 |
Why?
|
| Humans | 199 | 2025 | 768171 | 0.470 |
Why?
|
| Neurons | 7 | 2024 | 9514 | 0.470 |
Why?
|
| Glycolysis | 4 | 2013 | 837 | 0.470 |
Why?
|
| Receptors, Erythropoietin | 1 | 2014 | 144 | 0.470 |
Why?
|
| Acinetobacter Infections | 1 | 2015 | 73 | 0.460 |
Why?
|
| Immunophenotyping | 3 | 2014 | 1864 | 0.460 |
Why?
|
| Acute-Phase Proteins | 5 | 2009 | 252 | 0.460 |
Why?
|
| Social Isolation | 4 | 2012 | 366 | 0.450 |
Why?
|
| Cell Membrane | 11 | 2016 | 3655 | 0.450 |
Why?
|
| Hematoxylin | 1 | 2013 | 61 | 0.450 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2013 | 70 | 0.450 |
Why?
|
| Electrolytes | 4 | 2007 | 279 | 0.450 |
Why?
|
| Hippocampus | 6 | 2015 | 3783 | 0.450 |
Why?
|
| Epidermis | 3 | 2015 | 539 | 0.440 |
Why?
|
| Graft Survival | 8 | 2019 | 3887 | 0.440 |
Why?
|
| Macrophages | 8 | 2023 | 5802 | 0.440 |
Why?
|
| Acinetobacter baumannii | 1 | 2015 | 123 | 0.440 |
Why?
|
| Gene Regulatory Networks | 3 | 2011 | 1752 | 0.440 |
Why?
|
| Adipocytes | 2 | 2011 | 1199 | 0.440 |
Why?
|
| Galactosamine | 5 | 2006 | 26 | 0.440 |
Why?
|
| Stem Cell Transplantation | 4 | 2014 | 1599 | 0.430 |
Why?
|
| Glycoproteins | 5 | 2015 | 2202 | 0.430 |
Why?
|
| Microvessels | 3 | 2016 | 585 | 0.420 |
Why?
|
| Interleukin-1beta | 4 | 2025 | 1028 | 0.420 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 150 | 0.420 |
Why?
|
| Blood Preservation | 2 | 2024 | 169 | 0.420 |
Why?
|
| Stomach | 2 | 2017 | 701 | 0.420 |
Why?
|
| Drug Design | 2 | 2016 | 1046 | 0.420 |
Why?
|
| Catheterization, Peripheral | 1 | 2016 | 347 | 0.420 |
Why?
|
| Proteome | 4 | 2010 | 1890 | 0.410 |
Why?
|
| Protein Engineering | 3 | 2021 | 553 | 0.410 |
Why?
|
| Triglycerides | 8 | 2017 | 2464 | 0.410 |
Why?
|
| Glucagon | 5 | 2016 | 535 | 0.410 |
Why?
|
| Signal Transduction | 16 | 2020 | 23648 | 0.410 |
Why?
|
| Brain Injuries | 3 | 2015 | 2057 | 0.400 |
Why?
|
| Stress, Physiological | 4 | 2014 | 1408 | 0.400 |
Why?
|
| Acetaminophen | 2 | 2016 | 552 | 0.390 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 979 | 0.390 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2011 | 30 | 0.390 |
Why?
|
| Hot Temperature | 9 | 2016 | 1440 | 0.390 |
Why?
|
| Immunoassay | 1 | 2015 | 746 | 0.380 |
Why?
|
| Freezing | 9 | 2022 | 311 | 0.380 |
Why?
|
| Extracorporeal Circulation | 3 | 2009 | 181 | 0.380 |
Why?
|
| Photochemotherapy | 7 | 1998 | 830 | 0.380 |
Why?
|
| Computational Biology | 4 | 2011 | 3567 | 0.380 |
Why?
|
| Proline | 2 | 2009 | 455 | 0.370 |
Why?
|
| Blood Proteins | 3 | 2005 | 1191 | 0.370 |
Why?
|
| NF-kappa B | 7 | 2016 | 2494 | 0.370 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 752 | 0.370 |
Why?
|
| Computer Simulation | 18 | 2016 | 6283 | 0.370 |
Why?
|
| Connexins | 2 | 2012 | 355 | 0.370 |
Why?
|
| Proteoglycans | 6 | 2015 | 809 | 0.360 |
Why?
|
| Nanocapsules | 1 | 2012 | 95 | 0.360 |
Why?
|
| Immunoglobulin Allotypes | 11 | 1985 | 52 | 0.360 |
Why?
|
| Membrane Potentials | 3 | 2009 | 1090 | 0.360 |
Why?
|
| Aging | 4 | 2023 | 8743 | 0.360 |
Why?
|
| Proteins | 12 | 2023 | 6009 | 0.360 |
Why?
|
| Blood Vessels | 1 | 2016 | 1110 | 0.360 |
Why?
|
| Cell Aggregation | 3 | 2007 | 238 | 0.360 |
Why?
|
| Protective Agents | 1 | 2012 | 151 | 0.360 |
Why?
|
| Endoderm | 2 | 2010 | 165 | 0.360 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 7 | 2009 | 505 | 0.360 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 183 | 0.360 |
Why?
|
| Organ Preservation Solutions | 5 | 2019 | 104 | 0.350 |
Why?
|
| Acute-Phase Reaction | 4 | 2005 | 91 | 0.350 |
Why?
|
| Microtechnology | 5 | 2017 | 70 | 0.350 |
Why?
|
| Germ Layers | 2 | 2007 | 72 | 0.350 |
Why?
|
| Regenerative Medicine | 2 | 2011 | 313 | 0.350 |
Why?
|
| Polymers | 8 | 2016 | 1630 | 0.350 |
Why?
|
| Thermodynamics | 10 | 2014 | 591 | 0.340 |
Why?
|
| Boron Compounds | 1 | 2012 | 196 | 0.340 |
Why?
|
| Hexuronic Acids | 4 | 2015 | 145 | 0.340 |
Why?
|
| Glucuronic Acid | 4 | 2015 | 150 | 0.340 |
Why?
|
| Basement Membrane | 3 | 2010 | 348 | 0.340 |
Why?
|
| Cell Adhesion | 11 | 2011 | 3097 | 0.340 |
Why?
|
| Alanine Transaminase | 6 | 2011 | 606 | 0.340 |
Why?
|
| Rats, Zucker | 4 | 2014 | 131 | 0.330 |
Why?
|
| Time Factors | 43 | 2024 | 40220 | 0.330 |
Why?
|
| Transplantation | 1 | 2011 | 221 | 0.330 |
Why?
|
| Interleukin-10 | 3 | 2014 | 1184 | 0.330 |
Why?
|
| Up-Regulation | 6 | 2020 | 4149 | 0.330 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2015 | 621 | 0.330 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 257 | 0.330 |
Why?
|
| Microsomes, Liver | 1 | 2009 | 174 | 0.320 |
Why?
|
| Interferon Regulatory Factor-3 | 3 | 2020 | 146 | 0.320 |
Why?
|
| Lentivirus | 1 | 2012 | 518 | 0.320 |
Why?
|
| Culture Techniques | 7 | 1998 | 530 | 0.320 |
Why?
|
| Cicatrix | 3 | 2024 | 798 | 0.320 |
Why?
|
| Moloney murine leukemia virus | 1 | 2008 | 110 | 0.310 |
Why?
|
| Hydrogen Peroxide | 4 | 2024 | 741 | 0.310 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 1110 | 0.310 |
Why?
|
| Genetic Vectors | 5 | 2012 | 3403 | 0.300 |
Why?
|
| Immunosorbents | 3 | 1992 | 21 | 0.300 |
Why?
|
| Guided Tissue Regeneration | 1 | 2009 | 87 | 0.300 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 5 | 2009 | 283 | 0.300 |
Why?
|
| Muscle Proteins | 4 | 2021 | 1165 | 0.300 |
Why?
|
| Solutions | 4 | 2018 | 409 | 0.300 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2006 | 299 | 0.300 |
Why?
|
| Cell Transplantation | 1 | 2010 | 475 | 0.300 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1524 | 0.300 |
Why?
|
| Hemagglutinins | 1 | 2008 | 111 | 0.300 |
Why?
|
| Ectoderm | 1 | 2008 | 138 | 0.300 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2008 | 223 | 0.290 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2008 | 209 | 0.290 |
Why?
|
| Ice | 6 | 2022 | 102 | 0.290 |
Why?
|
| Cytokines | 9 | 2020 | 7452 | 0.290 |
Why?
|
| Male | 100 | 2025 | 364731 | 0.290 |
Why?
|
| Heat-Shock Proteins | 2 | 2009 | 797 | 0.290 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 1999 | 142 | 0.290 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 1238 | 0.290 |
Why?
|
| Gene Expression Regulation | 14 | 2020 | 11930 | 0.290 |
Why?
|
| Spheroids, Cellular | 3 | 2020 | 331 | 0.280 |
Why?
|
| Genes, Immediate-Early | 1 | 2007 | 102 | 0.280 |
Why?
|
| Female | 91 | 2025 | 397187 | 0.280 |
Why?
|
| Ion-Selective Electrodes | 1 | 2006 | 6 | 0.280 |
Why?
|
| Connexin 43 | 1 | 2008 | 202 | 0.280 |
Why?
|
| Pentose Phosphate Pathway | 5 | 2013 | 126 | 0.280 |
Why?
|
| Glycogen | 2 | 2010 | 252 | 0.280 |
Why?
|
| Electrophysiology | 1 | 2010 | 1266 | 0.280 |
Why?
|
| Cluster Analysis | 6 | 2014 | 2732 | 0.280 |
Why?
|
| Ligands | 3 | 2011 | 3284 | 0.280 |
Why?
|
| Aspartate Aminotransferases | 4 | 2010 | 414 | 0.280 |
Why?
|
| Pressure Ulcer | 2 | 2019 | 159 | 0.280 |
Why?
|
| Drug Discovery | 3 | 2011 | 1068 | 0.280 |
Why?
|
| Hemoperfusion | 1 | 2006 | 13 | 0.270 |
Why?
|
| Muscle, Skeletal | 6 | 2021 | 4978 | 0.270 |
Why?
|
| Gene Expression | 11 | 2014 | 7601 | 0.270 |
Why?
|
| Sialoglycoproteins | 2 | 2006 | 320 | 0.270 |
Why?
|
| Optics and Photonics | 1 | 2008 | 307 | 0.270 |
Why?
|
| Dextrans | 8 | 1996 | 574 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 14 | 2017 | 22380 | 0.270 |
Why?
|
| Apolipoproteins B | 1 | 2008 | 386 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2008 | 2486 | 0.260 |
Why?
|
| Blotting, Western | 7 | 2015 | 5028 | 0.260 |
Why?
|
| Activins | 1 | 2007 | 211 | 0.260 |
Why?
|
| Transcription, Genetic | 10 | 2011 | 7609 | 0.260 |
Why?
|
| Homeostasis | 1 | 2017 | 3348 | 0.260 |
Why?
|
| NIH 3T3 Cells | 4 | 2010 | 669 | 0.260 |
Why?
|
| Spleen | 4 | 2010 | 2296 | 0.250 |
Why?
|
| Surface Properties | 7 | 2023 | 1166 | 0.250 |
Why?
|
| Protein Biosynthesis | 5 | 2014 | 2094 | 0.250 |
Why?
|
| Butyrates | 1 | 2006 | 167 | 0.250 |
Why?
|
| Gluconeogenesis | 5 | 2010 | 185 | 0.250 |
Why?
|
| Muscular Atrophy | 2 | 2006 | 335 | 0.250 |
Why?
|
| Monocytes | 3 | 2025 | 2605 | 0.250 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2010 | 3115 | 0.250 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 406 | 0.250 |
Why?
|
| Cell Death | 5 | 2014 | 1680 | 0.250 |
Why?
|
| Escherichia coli Infections | 5 | 2000 | 524 | 0.250 |
Why?
|
| Macromolecular Substances | 5 | 2004 | 1435 | 0.250 |
Why?
|
| Liver Function Tests | 5 | 2020 | 526 | 0.250 |
Why?
|
| Genetic Engineering | 2 | 2003 | 936 | 0.250 |
Why?
|
| Action Potentials | 2 | 2010 | 1838 | 0.250 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2517 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2024 | 1887 | 0.240 |
Why?
|
| Electromagnetic Fields | 2 | 2019 | 289 | 0.240 |
Why?
|
| Chondroitin ABC Lyase | 2 | 2022 | 15 | 0.240 |
Why?
|
| Magnetics | 3 | 2021 | 597 | 0.240 |
Why?
|
| Transplantation Conditioning | 2 | 2014 | 1601 | 0.240 |
Why?
|
| Embryo, Mammalian | 3 | 2006 | 1676 | 0.230 |
Why?
|
| Immunoconjugates | 2 | 2007 | 975 | 0.230 |
Why?
|
| Ketone Bodies | 4 | 2014 | 76 | 0.230 |
Why?
|
| Electricity | 2 | 2015 | 175 | 0.230 |
Why?
|
| Citric Acid Cycle | 3 | 2003 | 234 | 0.230 |
Why?
|
| Retinal Detachment | 1 | 2009 | 429 | 0.230 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2017 | 9016 | 0.230 |
Why?
|
| Dehydroepiandrosterone | 1 | 2005 | 259 | 0.230 |
Why?
|
| Apoptosis | 7 | 2020 | 9527 | 0.230 |
Why?
|
| Virus Replication | 5 | 2007 | 2458 | 0.230 |
Why?
|
| Erythrocytes | 3 | 2024 | 2418 | 0.230 |
Why?
|
| Receptors, Virus | 3 | 2006 | 651 | 0.230 |
Why?
|
| Vitrification | 2 | 2021 | 52 | 0.230 |
Why?
|
| Astrocytes | 1 | 2012 | 1350 | 0.220 |
Why?
|
| Metabolome | 1 | 2011 | 1009 | 0.220 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2015 | 945 | 0.220 |
Why?
|
| Swine, Miniature | 1 | 2006 | 965 | 0.220 |
Why?
|
| Protein Conformation | 7 | 2021 | 3956 | 0.220 |
Why?
|
| Oxidative Stress | 6 | 2024 | 3140 | 0.220 |
Why?
|
| Mitogens | 1 | 2004 | 229 | 0.220 |
Why?
|
| Artificial Organs | 3 | 1994 | 149 | 0.220 |
Why?
|
| Cells | 2 | 2008 | 166 | 0.220 |
Why?
|
| RNA, Viral | 2 | 2011 | 2874 | 0.220 |
Why?
|
| Escherichia coli | 6 | 2016 | 4213 | 0.220 |
Why?
|
| Microchip Analytical Procedures | 1 | 2023 | 29 | 0.220 |
Why?
|
| Digoxigenin | 2 | 2000 | 26 | 0.220 |
Why?
|
| beta-Galactosidase | 4 | 1999 | 575 | 0.220 |
Why?
|
| Cell Movement | 5 | 2013 | 5213 | 0.220 |
Why?
|
| Pancreas | 1 | 2010 | 1699 | 0.220 |
Why?
|
| Intestinal Diseases | 1 | 2008 | 505 | 0.220 |
Why?
|
| Cell Physiological Phenomena | 2 | 2007 | 152 | 0.220 |
Why?
|
| Photosensitizing Agents | 4 | 1998 | 629 | 0.220 |
Why?
|
| Receptors, LDL | 1 | 2006 | 493 | 0.210 |
Why?
|
| Viral Core Proteins | 3 | 2011 | 158 | 0.210 |
Why?
|
| Docosahexaenoic Acids | 2 | 2025 | 914 | 0.210 |
Why?
|
| Gene Silencing | 2 | 2016 | 1505 | 0.210 |
Why?
|
| Cytochrome P-450 CYP1A1 | 4 | 2014 | 88 | 0.210 |
Why?
|
| Antibodies, Neoplasm | 4 | 1992 | 283 | 0.210 |
Why?
|
| Reproducibility of Results | 15 | 2023 | 20225 | 0.210 |
Why?
|
| Interferon-gamma | 4 | 2011 | 3161 | 0.210 |
Why?
|
| Cytosol | 2 | 2017 | 887 | 0.210 |
Why?
|
| Mice, Nude | 18 | 2014 | 3623 | 0.210 |
Why?
|
| Lipid Metabolism | 3 | 2010 | 1904 | 0.210 |
Why?
|
| Algorithms | 8 | 2016 | 14164 | 0.210 |
Why?
|
| Protein Interaction Mapping | 2 | 2007 | 622 | 0.210 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2019 | 591 | 0.210 |
Why?
|
| Blood Chemical Analysis | 1 | 2004 | 435 | 0.200 |
Why?
|
| Heparin Antagonists | 1 | 2002 | 34 | 0.200 |
Why?
|
| Hepatitis, Chronic | 1 | 2002 | 53 | 0.200 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2709 | 0.200 |
Why?
|
| Cell Respiration | 1 | 2003 | 201 | 0.200 |
Why?
|
| Colon | 1 | 2010 | 1801 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3814 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4585 | 0.200 |
Why?
|
| Mitochondria | 7 | 2023 | 3683 | 0.200 |
Why?
|
| Carbon | 2 | 2007 | 672 | 0.200 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2747 | 0.200 |
Why?
|
| Tin | 5 | 1994 | 13 | 0.200 |
Why?
|
| Lymph Nodes | 3 | 2010 | 3474 | 0.200 |
Why?
|
| Organoids | 3 | 2015 | 743 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2009 | 3806 | 0.200 |
Why?
|
| Thrombosis | 2 | 2013 | 2957 | 0.200 |
Why?
|
| Colitis | 1 | 2010 | 1242 | 0.190 |
Why?
|
| Antigens | 2 | 2021 | 1443 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2021 | 3463 | 0.190 |
Why?
|
| Citrus paradisi | 3 | 2011 | 9 | 0.190 |
Why?
|
| Growth Substances | 1 | 2004 | 760 | 0.190 |
Why?
|
| Cytoskeleton | 7 | 2023 | 1179 | 0.190 |
Why?
|
| Models, Theoretical | 7 | 2023 | 3573 | 0.190 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2001 | 462 | 0.190 |
Why?
|
| Calcium Channels | 2 | 2011 | 623 | 0.190 |
Why?
|
| Hormones | 2 | 2003 | 866 | 0.190 |
Why?
|
| Micelles | 1 | 2022 | 191 | 0.190 |
Why?
|
| Shock | 1 | 2004 | 316 | 0.190 |
Why?
|
| Methylcholanthrene | 2 | 2016 | 30 | 0.190 |
Why?
|
| Drug Interactions | 3 | 2022 | 1419 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 9 | 2001 | 6124 | 0.180 |
Why?
|
| Polyethylene Glycols | 6 | 2019 | 1197 | 0.180 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2020 | 142 | 0.180 |
Why?
|
| Immunoglobulin G | 15 | 2010 | 4568 | 0.180 |
Why?
|
| Histocytochemistry | 2 | 2013 | 699 | 0.180 |
Why?
|
| Reactive Oxygen Species | 5 | 2019 | 2152 | 0.180 |
Why?
|
| Collagen Type I | 3 | 2015 | 620 | 0.180 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 264 | 0.180 |
Why?
|
| DNA, Recombinant | 2 | 1999 | 455 | 0.180 |
Why?
|
| Donor Selection | 2 | 2013 | 240 | 0.180 |
Why?
|
| Asialoglycoproteins | 2 | 1997 | 19 | 0.180 |
Why?
|
| Gene Transfer Techniques | 6 | 2002 | 1207 | 0.180 |
Why?
|
| Central Nervous System | 1 | 2008 | 1346 | 0.180 |
Why?
|
| Islets of Langerhans | 3 | 1993 | 1351 | 0.180 |
Why?
|
| Sensitivity and Specificity | 9 | 2016 | 14729 | 0.180 |
Why?
|
| Antibody Affinity | 5 | 2006 | 252 | 0.180 |
Why?
|
| Citrates | 1 | 2000 | 134 | 0.180 |
Why?
|
| Models, Animal | 6 | 2016 | 2122 | 0.180 |
Why?
|
| Acids | 1 | 2001 | 125 | 0.180 |
Why?
|
| Thymus Hormones | 1 | 1999 | 1 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2008 | 2334 | 0.170 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 17142 | 0.170 |
Why?
|
| Oxidation-Reduction | 8 | 2020 | 2227 | 0.170 |
Why?
|
| Porosity | 2 | 2012 | 352 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2018 | 10763 | 0.170 |
Why?
|
| DNA Primers | 4 | 2008 | 2828 | 0.170 |
Why?
|
| Autoimmunity | 1 | 2008 | 1361 | 0.170 |
Why?
|
| Equipment Failure Analysis | 4 | 2010 | 845 | 0.170 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 999 | 0.170 |
Why?
|
| Haptoglobins | 2 | 2020 | 165 | 0.170 |
Why?
|
| Transcription Factors | 10 | 2014 | 12171 | 0.170 |
Why?
|
| Cattle | 9 | 2007 | 3819 | 0.170 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2020 | 118 | 0.170 |
Why?
|
| PPAR gamma | 3 | 2011 | 487 | 0.170 |
Why?
|
| Stem Cell Niche | 2 | 2013 | 347 | 0.170 |
Why?
|
| Electric Impedance | 3 | 2014 | 795 | 0.160 |
Why?
|
| Diffuse Axonal Injury | 1 | 2019 | 49 | 0.160 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2019 | 90 | 0.160 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2009 | 28 | 0.160 |
Why?
|
| Xenobiotics | 2 | 2018 | 71 | 0.160 |
Why?
|
| Bile Ducts | 1 | 2020 | 288 | 0.160 |
Why?
|
| Glycosaminoglycans | 2 | 1999 | 611 | 0.160 |
Why?
|
| Laminin | 4 | 2015 | 405 | 0.160 |
Why?
|
| Radiation-Sensitizing Agents | 3 | 1996 | 348 | 0.160 |
Why?
|
| Materials Testing | 4 | 2024 | 873 | 0.160 |
Why?
|
| Antibody Specificity | 7 | 1991 | 1065 | 0.160 |
Why?
|
| Fluoresceins | 6 | 2008 | 235 | 0.160 |
Why?
|
| Enzyme Induction | 4 | 2022 | 455 | 0.160 |
Why?
|
| Dynamins | 1 | 2019 | 141 | 0.160 |
Why?
|
| Endotoxemia | 2 | 2010 | 198 | 0.160 |
Why?
|
| Cold Ischemia | 2 | 2019 | 72 | 0.160 |
Why?
|
| Dimethyl Sulfoxide | 6 | 1993 | 250 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 709 | 0.160 |
Why?
|
| Metalloporphyrins | 3 | 1998 | 41 | 0.160 |
Why?
|
| Neural Pathways | 1 | 2010 | 3117 | 0.160 |
Why?
|
| Stress, Mechanical | 4 | 2013 | 1680 | 0.160 |
Why?
|
| HMGB1 Protein | 1 | 2020 | 141 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2014 | 1134 | 0.160 |
Why?
|
| RNA, Small Interfering | 3 | 2023 | 3428 | 0.160 |
Why?
|
| Mitosis | 1 | 2004 | 1178 | 0.160 |
Why?
|
| Intestinal Absorption | 5 | 2012 | 401 | 0.160 |
Why?
|
| Hepatic Stellate Cells | 2 | 2016 | 117 | 0.150 |
Why?
|
| Tachycardia | 1 | 2020 | 599 | 0.150 |
Why?
|
| Indoleacetic Acids | 1 | 2018 | 44 | 0.150 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 242 | 0.150 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2020 | 162 | 0.150 |
Why?
|
| Lac Operon | 5 | 1999 | 237 | 0.150 |
Why?
|
| Amiodarone | 1 | 2019 | 217 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1596 | 0.150 |
Why?
|
| Cell Membrane Permeability | 5 | 2014 | 573 | 0.150 |
Why?
|
| Tryptamines | 1 | 2018 | 93 | 0.150 |
Why?
|
| Cell Line, Transformed | 2 | 2011 | 866 | 0.150 |
Why?
|
| Adaptation, Physiological | 4 | 2017 | 1312 | 0.150 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 1037 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 835 | 0.150 |
Why?
|
| Permeability | 5 | 2014 | 726 | 0.150 |
Why?
|
| Tretinoin | 2 | 2011 | 525 | 0.150 |
Why?
|
| Nerve Net | 1 | 2010 | 2352 | 0.140 |
Why?
|
| Leukocytes | 3 | 2011 | 2034 | 0.140 |
Why?
|
| Satiety Response | 1 | 2017 | 47 | 0.140 |
Why?
|
| Motor Activity | 1 | 2007 | 2711 | 0.140 |
Why?
|
| Cell Count | 5 | 2013 | 1832 | 0.140 |
Why?
|
| Hydrogels | 2 | 2021 | 744 | 0.140 |
Why?
|
| Rifampin | 1 | 2019 | 352 | 0.140 |
Why?
|
| Isotopes | 1 | 1997 | 125 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 262 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2009 | 3080 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2010 | 7876 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2007 | 2238 | 0.140 |
Why?
|
| Antigens, Neoplasm | 8 | 1994 | 1996 | 0.140 |
Why?
|
| Therapeutics | 1 | 1997 | 113 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2003 | 684 | 0.140 |
Why?
|
| Nylons | 2 | 2014 | 46 | 0.140 |
Why?
|
| Environment | 2 | 2011 | 1121 | 0.140 |
Why?
|
| Bilirubin | 2 | 2009 | 438 | 0.130 |
Why?
|
| Adoptive Transfer | 2 | 2010 | 825 | 0.130 |
Why?
|
| Gels | 5 | 2015 | 423 | 0.130 |
Why?
|
| Diffusion | 4 | 2012 | 815 | 0.130 |
Why?
|
| Magnetite Nanoparticles | 1 | 2018 | 312 | 0.130 |
Why?
|
| Cations | 3 | 2007 | 240 | 0.130 |
Why?
|
| Fluorescent Dyes | 3 | 2021 | 1931 | 0.130 |
Why?
|
| Cell Hypoxia | 3 | 2015 | 662 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 6 | 2014 | 2634 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 1246 | 0.130 |
Why?
|
| Recombinant Proteins | 7 | 2021 | 6512 | 0.130 |
Why?
|
| Rabbits | 14 | 1999 | 4773 | 0.130 |
Why?
|
| Drug Combinations | 4 | 2015 | 2089 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2018 | 376 | 0.130 |
Why?
|
| U937 Cells | 2 | 2006 | 260 | 0.130 |
Why?
|
| Nucleic Acids | 1 | 1999 | 189 | 0.130 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2016 | 91 | 0.130 |
Why?
|
| Tryptophan | 1 | 2018 | 482 | 0.130 |
Why?
|
| Microtubules | 4 | 2023 | 1064 | 0.130 |
Why?
|
| Adsorption | 5 | 2002 | 198 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1999 | 549 | 0.130 |
Why?
|
| RNA, Messenger | 11 | 2009 | 12801 | 0.130 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2017 | 264 | 0.130 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 809 | 0.130 |
Why?
|
| Neoplasms | 7 | 2014 | 22371 | 0.130 |
Why?
|
| Mass Spectrometry | 4 | 2009 | 2202 | 0.130 |
Why?
|
| Swine | 8 | 2013 | 5997 | 0.130 |
Why?
|
| Liver Neoplasms | 3 | 2008 | 4363 | 0.130 |
Why?
|
| Phlebotomy | 1 | 2016 | 138 | 0.130 |
Why?
|
| Hep G2 Cells | 4 | 2018 | 378 | 0.130 |
Why?
|
| Flow Cytometry | 6 | 2011 | 5902 | 0.130 |
Why?
|
| Antibodies | 4 | 2011 | 2421 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2004 | 986 | 0.120 |
Why?
|
| Immunoglobulins | 4 | 1990 | 855 | 0.120 |
Why?
|
| Oncostatin M | 2 | 2008 | 42 | 0.120 |
Why?
|
| Peptide Fragments | 3 | 2021 | 5151 | 0.120 |
Why?
|
| Resuscitation | 1 | 2020 | 679 | 0.120 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 159 | 0.120 |
Why?
|
| Bile Acids and Salts | 4 | 2020 | 399 | 0.120 |
Why?
|
| Hydrostatic Pressure | 3 | 2000 | 99 | 0.120 |
Why?
|
| Electric Stimulation | 2 | 2011 | 1741 | 0.120 |
Why?
|
| Genes, Reporter | 5 | 2017 | 1524 | 0.120 |
Why?
|
| Systems Integration | 2 | 2007 | 430 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 4 | 2020 | 1370 | 0.120 |
Why?
|
| Adipose Tissue | 2 | 2019 | 3334 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 5 | 2015 | 1657 | 0.120 |
Why?
|
| Bacteriolysis | 1 | 1994 | 51 | 0.120 |
Why?
|
| Melanoma, Experimental | 4 | 1992 | 559 | 0.120 |
Why?
|
| Lasers | 4 | 2008 | 952 | 0.120 |
Why?
|
| Electrochemotherapy | 1 | 2014 | 5 | 0.120 |
Why?
|
| Sebaceous Glands | 1 | 2014 | 42 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2014 | 412 | 0.120 |
Why?
|
| Laser Coagulation | 1 | 1997 | 333 | 0.120 |
Why?
|
| Partial Pressure | 3 | 2006 | 248 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2005 | 12077 | 0.120 |
Why?
|
| Forkhead Transcription Factors | 2 | 2013 | 1625 | 0.120 |
Why?
|
| Thymus Gland | 1 | 1999 | 1266 | 0.120 |
Why?
|
| Adenoviridae | 3 | 2011 | 1093 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.120 |
Why?
|
| Genetic Techniques | 1 | 1997 | 428 | 0.120 |
Why?
|
| Chlorophyllides | 4 | 1996 | 54 | 0.120 |
Why?
|
| DNA, Antisense | 1 | 1994 | 44 | 0.110 |
Why?
|
| Acetyl Coenzyme A | 1 | 2014 | 74 | 0.110 |
Why?
|
| Bacterial Load | 1 | 2015 | 154 | 0.110 |
Why?
|
| History, 18th Century | 2 | 2014 | 206 | 0.110 |
Why?
|
| Contracture | 1 | 1997 | 236 | 0.110 |
Why?
|
| Protein Array Analysis | 2 | 2007 | 399 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2010 | 1968 | 0.110 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 457 | 0.110 |
Why?
|
| Trehalose | 2 | 2011 | 88 | 0.110 |
Why?
|
| Hypoglycemic Agents | 3 | 2016 | 3109 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2014 | 101 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2020 | 1531 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 1998 | 737 | 0.110 |
Why?
|
| Fatty Acids | 5 | 2020 | 1812 | 0.110 |
Why?
|
| Tissue Distribution | 8 | 2013 | 2300 | 0.110 |
Why?
|
| Protein Binding | 4 | 2014 | 9343 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 9 | 2019 | 6231 | 0.110 |
Why?
|
| Enkephalins | 1 | 2014 | 139 | 0.110 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 2023 | 394 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4415 | 0.110 |
Why?
|
| Drug Delivery Systems | 5 | 2016 | 2237 | 0.110 |
Why?
|
| Immune Tolerance | 3 | 2008 | 2323 | 0.110 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2006 | 394 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2020 | 3517 | 0.110 |
Why?
|
| Models, Immunological | 2 | 2007 | 518 | 0.110 |
Why?
|
| Fibrinogen | 3 | 2009 | 891 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2006 | 268 | 0.110 |
Why?
|
| NAD | 1 | 2017 | 618 | 0.110 |
Why?
|
| Proteomics | 4 | 2015 | 3912 | 0.110 |
Why?
|
| Indium Radioisotopes | 2 | 1991 | 116 | 0.110 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 17623 | 0.110 |
Why?
|
| Online Systems | 1 | 1994 | 182 | 0.110 |
Why?
|
| Needles | 1 | 2016 | 461 | 0.110 |
Why?
|
| Microscopy, Phase-Contrast | 3 | 2006 | 110 | 0.110 |
Why?
|
| Molecular Weight | 8 | 2001 | 2173 | 0.110 |
Why?
|
| Melanoma | 6 | 2013 | 5706 | 0.110 |
Why?
|
| Calcium Channel Blockers | 2 | 2011 | 687 | 0.110 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 2008 | 93 | 0.110 |
Why?
|
| Bile | 2 | 2011 | 299 | 0.100 |
Why?
|
| Carnitine | 1 | 2014 | 253 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 4528 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2014 | 240 | 0.100 |
Why?
|
| Body Temperature | 2 | 2013 | 780 | 0.100 |
Why?
|
| Equipment and Supplies | 1 | 2015 | 274 | 0.100 |
Why?
|
| Actins | 7 | 2023 | 2064 | 0.100 |
Why?
|
| Animal Testing Alternatives | 1 | 2012 | 15 | 0.100 |
Why?
|
| Water | 2 | 2018 | 1421 | 0.100 |
Why?
|
| Polyribosomes | 1 | 1992 | 109 | 0.100 |
Why?
|
| Immunoglobulin Fragments | 1 | 1992 | 84 | 0.100 |
Why?
|
| Cadherins | 3 | 2011 | 905 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2008 | 13422 | 0.100 |
Why?
|
| Models, Molecular | 5 | 2014 | 5402 | 0.100 |
Why?
|
| Molecular Structure | 4 | 2011 | 1884 | 0.100 |
Why?
|
| Metabolomics | 2 | 2020 | 1674 | 0.100 |
Why?
|
| Hydrocortisone | 4 | 2003 | 1841 | 0.100 |
Why?
|
| Platelet-Derived Growth Factor | 4 | 2001 | 617 | 0.100 |
Why?
|
| Ammonia | 2 | 2004 | 247 | 0.100 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1750 | 0.100 |
Why?
|
| Thioacetamide | 1 | 2012 | 22 | 0.100 |
Why?
|
| History, 19th Century | 2 | 2014 | 714 | 0.100 |
Why?
|
| Nitric Oxide | 3 | 2007 | 2149 | 0.100 |
Why?
|
| Spectrophotometry | 2 | 2008 | 292 | 0.100 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2005 | 361 | 0.100 |
Why?
|
| Focal Infection | 1 | 1991 | 9 | 0.100 |
Why?
|
| Transgenes | 2 | 2008 | 1016 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2012 | 3409 | 0.100 |
Why?
|
| Administration, Cutaneous | 1 | 2014 | 716 | 0.100 |
Why?
|
| Receptors, Ionotropic Glutamate | 1 | 2011 | 8 | 0.100 |
Why?
|
| Purinergic Antagonists | 1 | 2011 | 10 | 0.100 |
Why?
|
| Rats, Inbred Strains | 7 | 1992 | 2087 | 0.100 |
Why?
|
| Diptera | 1 | 2011 | 50 | 0.100 |
Why?
|
| Decision Trees | 1 | 2013 | 508 | 0.100 |
Why?
|
| Lipoproteins, LDL | 3 | 1989 | 644 | 0.100 |
Why?
|
| Desiccation | 1 | 2011 | 78 | 0.100 |
Why?
|
| Housing, Animal | 1 | 2011 | 47 | 0.100 |
Why?
|
| Drugs, Investigational | 1 | 2013 | 211 | 0.100 |
Why?
|
| Cells, Immobilized | 1 | 2011 | 37 | 0.090 |
Why?
|
| Protein Precursors | 2 | 2014 | 1135 | 0.090 |
Why?
|
| Hepatectomy | 2 | 2012 | 588 | 0.090 |
Why?
|
| Tin Compounds | 1 | 1991 | 8 | 0.090 |
Why?
|
| Light | 7 | 1995 | 1355 | 0.090 |
Why?
|
| Receptors, Purinergic | 1 | 2011 | 66 | 0.090 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1992 | 112 | 0.090 |
Why?
|
| Jejunum | 1 | 2013 | 475 | 0.090 |
Why?
|
| Gases | 1 | 2012 | 205 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 1683 | 0.090 |
Why?
|
| Interleukin-8 | 1 | 2014 | 705 | 0.090 |
Why?
|
| beta-Cyclodextrins | 1 | 2011 | 67 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 876 | 0.090 |
Why?
|
| Transplantation Immunology | 1 | 2013 | 537 | 0.090 |
Why?
|
| Cell Polarity | 2 | 2009 | 639 | 0.090 |
Why?
|
| Kupffer Cells | 2 | 2013 | 143 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2010 | 65 | 0.090 |
Why?
|
| Veratrum Alkaloids | 1 | 2010 | 23 | 0.090 |
Why?
|
| Lectins, C-Type | 1 | 2014 | 594 | 0.090 |
Why?
|
| Pattern Recognition, Automated | 2 | 2014 | 993 | 0.090 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 2 | 2002 | 57 | 0.090 |
Why?
|
| Static Electricity | 2 | 2004 | 260 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 2956 | 0.090 |
Why?
|
| Biofilms | 1 | 2015 | 634 | 0.090 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2013 | 286 | 0.090 |
Why?
|
| Hydrogen Bonding | 1 | 2011 | 290 | 0.090 |
Why?
|
| Hair | 1 | 2014 | 508 | 0.090 |
Why?
|
| Flow Injection Analysis | 2 | 2007 | 21 | 0.090 |
Why?
|
| Cytological Techniques | 2 | 2011 | 218 | 0.090 |
Why?
|
| Mesoderm | 2 | 2007 | 679 | 0.090 |
Why?
|
| Hybrid Cells | 2 | 1981 | 421 | 0.090 |
Why?
|
| Gastroplasty | 1 | 2012 | 159 | 0.090 |
Why?
|
| Postoperative Period | 2 | 2007 | 1826 | 0.090 |
Why?
|
| CHO Cells | 2 | 2011 | 1379 | 0.090 |
Why?
|
| Random Allocation | 3 | 2016 | 2395 | 0.090 |
Why?
|
| History of Medicine | 1 | 2011 | 42 | 0.090 |
Why?
|
| History, Ancient | 1 | 2011 | 213 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2011 | 173 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6229 | 0.090 |
Why?
|
| Compressive Strength | 1 | 2011 | 159 | 0.090 |
Why?
|
| Virus Assembly | 1 | 2011 | 141 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 61 | 0.090 |
Why?
|
| Insect Proteins | 1 | 2011 | 253 | 0.090 |
Why?
|
| Base Sequence | 6 | 2008 | 12422 | 0.090 |
Why?
|
| Receptors, Death Domain | 1 | 2010 | 31 | 0.090 |
Why?
|
| Muscles | 3 | 2010 | 1582 | 0.090 |
Why?
|
| Axons | 2 | 2022 | 1677 | 0.090 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2010 | 63 | 0.090 |
Why?
|
| Phototherapy | 2 | 1991 | 368 | 0.090 |
Why?
|
| Interleukin-4 | 1 | 2014 | 1156 | 0.090 |
Why?
|
| Anti-Ulcer Agents | 1 | 2011 | 112 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 800 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2014 | 6004 | 0.090 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2011 | 437 | 0.090 |
Why?
|
| Mice, Knockout | 8 | 2020 | 14488 | 0.090 |
Why?
|
| Lactic Acid | 3 | 2020 | 1140 | 0.090 |
Why?
|
| Autoradiography | 5 | 1991 | 728 | 0.090 |
Why?
|
| Microscopy | 2 | 1997 | 909 | 0.080 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1992 | 342 | 0.080 |
Why?
|
| Reference Values | 4 | 2016 | 4939 | 0.080 |
Why?
|
| Ethanol | 1 | 2016 | 1331 | 0.080 |
Why?
|
| Gastrectomy | 1 | 2015 | 693 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2011 | 251 | 0.080 |
Why?
|
| Mice, Inbred Strains | 5 | 2005 | 1769 | 0.080 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2011 | 196 | 0.080 |
Why?
|
| Cell Extracts | 1 | 2010 | 135 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 515 | 0.080 |
Why?
|
| 3T3-L1 Cells | 1 | 2010 | 208 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 341 | 0.080 |
Why?
|
| HeLa Cells | 3 | 2012 | 3074 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2014 | 966 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2020 | 2819 | 0.080 |
Why?
|
| Glutathione | 3 | 2019 | 589 | 0.080 |
Why?
|
| Hindlimb | 3 | 2004 | 516 | 0.080 |
Why?
|
| Cell Tracking | 1 | 2010 | 140 | 0.080 |
Why?
|
| Social Environment | 3 | 2011 | 1012 | 0.080 |
Why?
|
| Silver | 1 | 2010 | 119 | 0.080 |
Why?
|
| Bioengineering | 1 | 2010 | 101 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 306 | 0.080 |
Why?
|
| Drug Carriers | 3 | 2002 | 710 | 0.080 |
Why?
|
| Cellular Structures | 1 | 2009 | 9 | 0.080 |
Why?
|
| Staphylococcal Protein A | 1 | 1989 | 39 | 0.080 |
Why?
|
| HIV | 1 | 2016 | 1597 | 0.080 |
Why?
|
| Response Elements | 2 | 2010 | 308 | 0.080 |
Why?
|
| Food Preferences | 1 | 2012 | 398 | 0.080 |
Why?
|
| Muramidase | 2 | 1999 | 163 | 0.080 |
Why?
|
| Survival Rate | 5 | 2014 | 12840 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 195 | 0.080 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2008 | 68 | 0.080 |
Why?
|
| Databases, Protein | 1 | 2011 | 390 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 687 | 0.080 |
Why?
|
| Fluorescence Polarization | 2 | 1999 | 139 | 0.080 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 5891 | 0.080 |
Why?
|
| Binding, Competitive | 6 | 1996 | 1142 | 0.080 |
Why?
|
| Reverse Transcription | 1 | 2008 | 48 | 0.080 |
Why?
|
| Transplantation, Heterologous | 4 | 2008 | 2393 | 0.080 |
Why?
|
| Galactosyltransferases | 1 | 2010 | 284 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2003 | 2893 | 0.080 |
Why?
|
| Quartz | 1 | 2008 | 23 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 911 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2008 | 1802 | 0.080 |
Why?
|
| Photochemistry | 3 | 1995 | 238 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2010 | 11101 | 0.080 |
Why?
|
| E-Selectin | 1 | 2010 | 577 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 199 | 0.080 |
Why?
|
| Necrosis | 1 | 2012 | 1616 | 0.080 |
Why?
|
| Models, Statistical | 4 | 2015 | 5107 | 0.070 |
Why?
|
| Lymphocytes | 4 | 2002 | 2614 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2017 | 1682 | 0.070 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2011 | 427 | 0.070 |
Why?
|
| Electrophoresis | 1 | 1988 | 226 | 0.070 |
Why?
|
| Brain Concussion | 1 | 2019 | 1435 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 693 | 0.070 |
Why?
|
| Micromanipulation | 1 | 2008 | 53 | 0.070 |
Why?
|
| Nanostructures | 2 | 2016 | 553 | 0.070 |
Why?
|
| Scattering, Radiation | 5 | 1991 | 489 | 0.070 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 461 | 0.070 |
Why?
|
| Multienzyme Complexes | 3 | 2007 | 664 | 0.070 |
Why?
|
| Circular Dichroism | 1 | 2008 | 337 | 0.070 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2008 | 122 | 0.070 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 2512 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 3626 | 0.070 |
Why?
|
| Models, Genetic | 3 | 2008 | 3447 | 0.070 |
Why?
|
| Homozygote | 3 | 2009 | 1779 | 0.070 |
Why?
|
| Acrylic Resins | 1 | 2008 | 135 | 0.070 |
Why?
|
| Skin Transplantation | 3 | 1998 | 1097 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5797 | 0.070 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 179 | 0.070 |
Why?
|
| Fasting | 2 | 2010 | 1610 | 0.070 |
Why?
|
| Raffinose | 2 | 2019 | 57 | 0.070 |
Why?
|
| Embryonic Induction | 1 | 2007 | 152 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 3 | 2023 | 6082 | 0.070 |
Why?
|
| Heart Valves | 1 | 1989 | 284 | 0.070 |
Why?
|
| Viscosity | 3 | 2018 | 334 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2010 | 1251 | 0.070 |
Why?
|
| Antioxidants | 2 | 2024 | 1676 | 0.070 |
Why?
|
| Radioimmunoassay | 4 | 1994 | 863 | 0.070 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 551 | 0.070 |
Why?
|
| Shock, Septic | 1 | 2014 | 774 | 0.070 |
Why?
|
| Chemokines | 2 | 2011 | 963 | 0.070 |
Why?
|
| Deltaretrovirus Infections | 1 | 1986 | 25 | 0.070 |
Why?
|
| Binding Sites, Antibody | 3 | 1992 | 340 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2012 | 2683 | 0.070 |
Why?
|
| Phenotype | 4 | 2014 | 16726 | 0.070 |
Why?
|
| Miniaturization | 1 | 2007 | 154 | 0.070 |
Why?
|
| Neuroglia | 1 | 2013 | 960 | 0.070 |
Why?
|
| Cartilage | 1 | 2011 | 811 | 0.070 |
Why?
|
| Follistatin | 1 | 2007 | 138 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2014 | 4913 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 297 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2009 | 753 | 0.070 |
Why?
|
| Superoxides | 1 | 2008 | 389 | 0.070 |
Why?
|
| Neoplasm Transplantation | 5 | 2014 | 2014 | 0.070 |
Why?
|
| Neurites | 1 | 2008 | 389 | 0.070 |
Why?
|
| History, 20th Century | 2 | 2014 | 2766 | 0.070 |
Why?
|
| Neutrophils | 4 | 2012 | 3786 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 1993 | 1895 | 0.070 |
Why?
|
| Binding Sites | 3 | 2011 | 6019 | 0.070 |
Why?
|
| Radiography | 2 | 2013 | 6986 | 0.070 |
Why?
|
| Cell Shape | 1 | 2007 | 371 | 0.070 |
Why?
|
| Osmolar Concentration | 3 | 1999 | 657 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2014 | 4280 | 0.070 |
Why?
|
| Ligation | 1 | 2007 | 446 | 0.070 |
Why?
|
| Melanins | 1 | 2008 | 292 | 0.070 |
Why?
|
| Peptide Library | 1 | 2007 | 351 | 0.060 |
Why?
|
| Thalamus | 1 | 2012 | 1047 | 0.060 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2005 | 49 | 0.060 |
Why?
|
| Hemopexin | 1 | 2005 | 33 | 0.060 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 1892 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2011 | 1076 | 0.060 |
Why?
|
| Allopurinol | 2 | 2019 | 202 | 0.060 |
Why?
|
| Gastroenterology | 1 | 2012 | 593 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2008 | 611 | 0.060 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2008 | 541 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 4 | 1981 | 289 | 0.060 |
Why?
|
| Brain | 2 | 2011 | 27362 | 0.060 |
Why?
|
| Calcium | 1 | 1998 | 5792 | 0.060 |
Why?
|
| Mathematics | 4 | 1994 | 704 | 0.060 |
Why?
|
| Connective Tissue | 2 | 1999 | 425 | 0.060 |
Why?
|
| Oxytocin | 1 | 2009 | 404 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 166 | 0.060 |
Why?
|
| Rats, Long-Evans | 3 | 2013 | 380 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2013 | 2885 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1613 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 11095 | 0.060 |
Why?
|
| Wounds, Penetrating | 1 | 2007 | 316 | 0.060 |
Why?
|
| Acoustics | 2 | 2017 | 244 | 0.060 |
Why?
|
| Lipocalins | 1 | 2005 | 161 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2011 | 1573 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2008 | 674 | 0.060 |
Why?
|
| Biological Assay | 1 | 2007 | 628 | 0.060 |
Why?
|
| Chemical Phenomena | 3 | 1990 | 486 | 0.060 |
Why?
|
| Integrin alpha6 | 2 | 2014 | 30 | 0.060 |
Why?
|
| Body Surface Area | 3 | 2010 | 205 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1495 | 0.060 |
Why?
|
| Computer Systems | 1 | 2005 | 469 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2009 | 10099 | 0.060 |
Why?
|
| Cholesterol | 3 | 2013 | 2914 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2007 | 958 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 4428 | 0.060 |
Why?
|
| Oxidants | 1 | 2024 | 168 | 0.060 |
Why?
|
| Virion | 1 | 2006 | 429 | 0.060 |
Why?
|
| Pharmacokinetics | 3 | 2012 | 86 | 0.050 |
Why?
|
| Proton-Translocating ATPases | 1 | 2004 | 112 | 0.050 |
Why?
|
| Linear Models | 1 | 2013 | 5884 | 0.050 |
Why?
|
| Antimycin A | 1 | 2003 | 31 | 0.050 |
Why?
|
| Oligomycins | 1 | 2003 | 20 | 0.050 |
Why?
|
| Death | 1 | 2008 | 683 | 0.050 |
Why?
|
| Plasmids | 1 | 2008 | 2269 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2014 | 8316 | 0.050 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1985 | 355 | 0.050 |
Why?
|
| Radionuclide Imaging | 4 | 1992 | 2000 | 0.050 |
Why?
|
| Tissue Survival | 2 | 2019 | 120 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 874 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2006 | 377 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2010 | 2939 | 0.050 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2004 | 120 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2008 | 724 | 0.050 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 6669 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 2957 | 0.050 |
Why?
|
| Epitopes | 3 | 1987 | 2527 | 0.050 |
Why?
|
| Adult | 11 | 2025 | 223646 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2006 | 553 | 0.050 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1994 | 1483 | 0.050 |
Why?
|
| Hyperthermia, Induced | 1 | 2006 | 416 | 0.050 |
Why?
|
| Cell Division | 5 | 2001 | 4477 | 0.050 |
Why?
|
| Basal Metabolism | 1 | 2003 | 163 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 1994 | 3604 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2008 | 1530 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 165 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4064 | 0.050 |
Why?
|
| Heterozygote | 1 | 2009 | 2798 | 0.050 |
Why?
|
| Biomedical Technology | 1 | 2004 | 210 | 0.050 |
Why?
|
| Lipolysis | 1 | 2003 | 211 | 0.050 |
Why?
|
| Adenosine | 2 | 2019 | 822 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2024 | 594 | 0.050 |
Why?
|
| Antibodies, Bacterial | 5 | 2014 | 1478 | 0.050 |
Why?
|
| Immunoglobulin kappa-Chains | 5 | 1985 | 171 | 0.050 |
Why?
|
| Discriminant Analysis | 2 | 2012 | 222 | 0.050 |
Why?
|
| Biological Availability | 2 | 2014 | 391 | 0.050 |
Why?
|
| Feedback | 1 | 2005 | 799 | 0.050 |
Why?
|
| Lymphocyte Activation | 3 | 2011 | 5505 | 0.050 |
Why?
|
| Poloxamer | 1 | 2001 | 56 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 762 | 0.050 |
Why?
|
| Antigens, CD34 | 2 | 2014 | 657 | 0.050 |
Why?
|
| RNA | 2 | 2007 | 2722 | 0.050 |
Why?
|
| Least-Squares Analysis | 2 | 2012 | 367 | 0.050 |
Why?
|
| Gadolinium | 1 | 2006 | 964 | 0.050 |
Why?
|
| Cross-Linking Reagents | 2 | 1997 | 693 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1862 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 697 | 0.050 |
Why?
|
| Phenobarbital | 1 | 2001 | 192 | 0.050 |
Why?
|
| Glutathione Reductase | 1 | 2000 | 25 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2002 | 901 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 2430 | 0.050 |
Why?
|
| Biological Transport | 3 | 2011 | 2085 | 0.050 |
Why?
|
| Lipids | 1 | 2012 | 3345 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 267 | 0.050 |
Why?
|
| Isomerism | 2 | 1999 | 198 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 1992 | 525 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2010 | 2857 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 2682 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 1083 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2007 | 1361 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 1980 | 648 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 9617 | 0.040 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1980 | 58 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 2021 | 244 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 2001 | 235 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2013 | 6431 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 1997 | 354 | 0.040 |
Why?
|
| Lipoproteins, VLDL | 2 | 2011 | 201 | 0.040 |
Why?
|
| RNA Interference | 1 | 2009 | 2832 | 0.040 |
Why?
|
| Particle Size | 1 | 2024 | 1651 | 0.040 |
Why?
|
| Fibrinolysin | 1 | 2000 | 130 | 0.040 |
Why?
|
| Octamer Transcription Factor-3 | 2 | 2013 | 221 | 0.040 |
Why?
|
| Ethylene Glycol | 2 | 2008 | 31 | 0.040 |
Why?
|
| Phase Transition | 1 | 2019 | 70 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 8648 | 0.040 |
Why?
|
| Forecasting | 1 | 2009 | 2945 | 0.040 |
Why?
|
| Cathepsins | 1 | 2000 | 243 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2007 | 1816 | 0.040 |
Why?
|
| Immunologic Techniques | 2 | 1990 | 213 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 3948 | 0.040 |
Why?
|
| Mice, Inbred NOD | 2 | 2014 | 1837 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2020 | 418 | 0.040 |
Why?
|
| Carbon Radioisotopes | 1 | 2000 | 567 | 0.040 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2000 | 209 | 0.040 |
Why?
|
| Bicarbonates | 1 | 2020 | 293 | 0.040 |
Why?
|
| Singlet Oxygen | 2 | 1998 | 58 | 0.040 |
Why?
|
| HL-60 Cells | 2 | 2016 | 364 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1980 | 420 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2001 | 563 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 1998 | 74 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 366 | 0.040 |
Why?
|
| Xanthenes | 1 | 1998 | 71 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2012 | 948 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2011 | 2295 | 0.040 |
Why?
|
| Birefringence | 1 | 1998 | 54 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 283 | 0.040 |
Why?
|
| Suspensions | 1 | 2018 | 68 | 0.040 |
Why?
|
| Microcirculation | 2 | 2014 | 1281 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2017 | 65379 | 0.040 |
Why?
|
| Alkanes | 1 | 2018 | 39 | 0.040 |
Why?
|
| Ion Channels | 1 | 2003 | 1043 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 3533 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 1999 | 458 | 0.040 |
Why?
|
| Oils | 1 | 2018 | 54 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2012 | 1972 | 0.040 |
Why?
|
| Dogs | 2 | 2013 | 3845 | 0.040 |
Why?
|
| Alcohols | 1 | 2018 | 94 | 0.040 |
Why?
|
| Vacuum | 1 | 2018 | 65 | 0.040 |
Why?
|
| Nifedipine | 1 | 1998 | 220 | 0.040 |
Why?
|
| Receptors, Fc | 2 | 1992 | 537 | 0.040 |
Why?
|
| Axotomy | 1 | 2018 | 71 | 0.040 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2000 | 238 | 0.040 |
Why?
|
| Chemistry, Physical | 2 | 1988 | 153 | 0.040 |
Why?
|
| Verapamil | 1 | 1998 | 242 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1981 | 547 | 0.040 |
Why?
|
| Nickel | 1 | 1998 | 126 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 136 | 0.040 |
Why?
|
| Recombination, Genetic | 2 | 2000 | 1525 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 395 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2020 | 365 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2010 | 1353 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1277 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2007 | 162 | 0.040 |
Why?
|
| Solubility | 2 | 2011 | 1086 | 0.040 |
Why?
|
| Succinates | 1 | 1997 | 83 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2709 | 0.040 |
Why?
|
| Risk Factors | 3 | 2013 | 74944 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1999 | 897 | 0.040 |
Why?
|
| Chromatography, Gel | 1 | 1998 | 636 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 1999 | 794 | 0.040 |
Why?
|
| Antigens, Surface | 2 | 1993 | 1617 | 0.040 |
Why?
|
| Retina | 1 | 2008 | 2662 | 0.040 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 1996 | 15 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 1997 | 201 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1996 | 37 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2012 | 6684 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1996 | 48 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 3 | 1994 | 1627 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 1810 | 0.030 |
Why?
|
| Weight Loss | 2 | 2012 | 2721 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2020 | 939 | 0.030 |
Why?
|
| Capsid | 1 | 1999 | 435 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2023 | 1309 | 0.030 |
Why?
|
| Chickens | 1 | 1998 | 845 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2022 | 797 | 0.030 |
Why?
|
| Rhodamines | 2 | 2013 | 178 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4260 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1996 | 266 | 0.030 |
Why?
|
| Microscopy, Polarization | 1 | 2016 | 88 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 221 | 0.030 |
Why?
|
| Trypsin | 1 | 1996 | 491 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2020 | 4194 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7243 | 0.030 |
Why?
|
| Polypropylenes | 1 | 2015 | 63 | 0.030 |
Why?
|
| Disulfides | 1 | 1997 | 466 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 1996 | 193 | 0.030 |
Why?
|
| Vacuoles | 1 | 1996 | 224 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9561 | 0.030 |
Why?
|
| Carrier Proteins | 3 | 2011 | 4939 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 1996 | 209 | 0.030 |
Why?
|
| Skin Pigmentation | 1 | 1997 | 280 | 0.030 |
Why?
|
| Genomics | 2 | 2009 | 5926 | 0.030 |
Why?
|
| Telemetry | 2 | 2009 | 200 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 873 | 0.030 |
Why?
|
| Sound | 1 | 2017 | 261 | 0.030 |
Why?
|
| Ethylenediamines | 1 | 1994 | 57 | 0.030 |
Why?
|
| Melanoma-Specific Antigens | 2 | 1994 | 73 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 2018 | 921 | 0.030 |
Why?
|
| Poloxalene | 1 | 1994 | 2 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2017 | 838 | 0.030 |
Why?
|
| Lysosomes | 1 | 2000 | 938 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 1995 | 241 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8542 | 0.030 |
Why?
|
| Epinephrine | 1 | 1998 | 794 | 0.030 |
Why?
|
| Autonomic Nervous System | 1 | 1999 | 707 | 0.030 |
Why?
|
| Free Radicals | 1 | 1994 | 238 | 0.030 |
Why?
|
| Glass | 1 | 1994 | 116 | 0.030 |
Why?
|
| Drug Stability | 1 | 1994 | 292 | 0.030 |
Why?
|
| Body Weight | 3 | 2012 | 4627 | 0.030 |
Why?
|
| Heparin | 1 | 2001 | 1636 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2015 | 237 | 0.030 |
Why?
|
| Capillary Permeability | 2 | 2000 | 772 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 276 | 0.030 |
Why?
|
| Polyurethanes | 1 | 1994 | 110 | 0.030 |
Why?
|
| Microscopy, Atomic Force | 1 | 1994 | 250 | 0.030 |
Why?
|
| Saimiri | 3 | 1989 | 337 | 0.030 |
Why?
|
| Intestinal Mucosa | 4 | 2011 | 3044 | 0.030 |
Why?
|
| Myocardium | 2 | 2017 | 4790 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2013 | 2055 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1854 | 0.030 |
Why?
|
| Sutures | 1 | 2016 | 283 | 0.030 |
Why?
|
| Luminescent Measurements | 1 | 2015 | 342 | 0.030 |
Why?
|
| Cricetinae | 2 | 2011 | 2423 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 20762 | 0.030 |
Why?
|
| Digestion | 1 | 2013 | 53 | 0.030 |
Why?
|
| Biometry | 1 | 1997 | 570 | 0.030 |
Why?
|
| Rosette Formation | 2 | 1985 | 152 | 0.030 |
Why?
|
| Immunosorbent Techniques | 2 | 1992 | 174 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2359 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2004 | 2981 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 1993 | 110 | 0.030 |
Why?
|
| Biliary Tract | 1 | 2014 | 135 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 2019 | 506 | 0.030 |
Why?
|
| Bacteremia | 1 | 2000 | 985 | 0.030 |
Why?
|
| Phenylhydrazines | 1 | 1992 | 28 | 0.030 |
Why?
|
| Microvilli | 1 | 1993 | 235 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1996 | 480 | 0.030 |
Why?
|
| Hydrazines | 1 | 1994 | 223 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2013 | 186 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2020 | 4035 | 0.030 |
Why?
|
| Leukemia Virus, Murine | 1 | 1993 | 95 | 0.030 |
Why?
|
| Pepsin A | 1 | 1992 | 64 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1996 | 841 | 0.030 |
Why?
|
| Aniline Compounds | 1 | 1998 | 1094 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2013 | 351 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 1993 | 225 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1996 | 764 | 0.030 |
Why?
|
| Lactates | 1 | 2013 | 401 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 630 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1988 | 1730 | 0.030 |
Why?
|
| Ethanolamines | 1 | 1992 | 152 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1992 | 305 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2014 | 5315 | 0.020 |
Why?
|
| Cell Size | 1 | 1994 | 626 | 0.020 |
Why?
|
| Automation | 1 | 2014 | 589 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 506 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 719 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 1076 | 0.020 |
Why?
|
| Oxygenators, Membrane | 2 | 2002 | 57 | 0.020 |
Why?
|
| Whole-Body Counting | 1 | 1991 | 36 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 1992 | 242 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1997 | 1259 | 0.020 |
Why?
|
| Monitoring, Physiologic | 2 | 2002 | 1798 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 584 | 0.020 |
Why?
|
| Brefeldin A | 1 | 2011 | 68 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 729 | 0.020 |
Why?
|
| Purines | 1 | 2014 | 615 | 0.020 |
Why?
|
| Thiocyanates | 1 | 1991 | 70 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 453 | 0.020 |
Why?
|
| Middle Aged | 6 | 2025 | 223487 | 0.020 |
Why?
|
| Ablation Techniques | 1 | 2014 | 255 | 0.020 |
Why?
|
| Intestines | 2 | 2011 | 1909 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1992 | 446 | 0.020 |
Why?
|
| Length of Stay | 1 | 2025 | 6498 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2019 | 1812 | 0.020 |
Why?
|
| Lymphocyte Subsets | 2 | 2002 | 313 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1623 | 0.020 |
Why?
|
| Urine | 1 | 1992 | 362 | 0.020 |
Why?
|
| Complement C3a | 1 | 2010 | 66 | 0.020 |
Why?
|
| Antifibrinolytic Agents | 1 | 2013 | 289 | 0.020 |
Why?
|
| Apolipoprotein B-100 | 1 | 2011 | 157 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1992 | 1553 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 21207 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2011 | 367 | 0.020 |
Why?
|
| Chemistry | 1 | 1990 | 327 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1992 | 389 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2018 | 2003 | 0.020 |
Why?
|
| Implants, Experimental | 1 | 2010 | 99 | 0.020 |
Why?
|
| Tomography | 1 | 2012 | 442 | 0.020 |
Why?
|
| Obesity | 1 | 2012 | 13091 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13668 | 0.020 |
Why?
|
| Streptococcus | 3 | 1980 | 198 | 0.020 |
Why?
|
| Larva | 1 | 2011 | 515 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 812 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 1990 | 411 | 0.020 |
Why?
|
| Fibronectins | 1 | 1993 | 722 | 0.020 |
Why?
|
| Ethylene Glycols | 1 | 1991 | 198 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 311 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2014 | 2627 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 1997 | 3782 | 0.020 |
Why?
|
| Horseradish Peroxidase | 1 | 1989 | 170 | 0.020 |
Why?
|
| Rheology | 2 | 2001 | 348 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2010 | 177 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2002 | 1305 | 0.020 |
Why?
|
| Viruses | 1 | 1993 | 373 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1991 | 2560 | 0.020 |
Why?
|
| Video Recording | 1 | 1994 | 976 | 0.020 |
Why?
|
| Ascites | 2 | 1981 | 338 | 0.020 |
Why?
|
| Fibrosis | 1 | 2016 | 2081 | 0.020 |
Why?
|
| Thermal Conductivity | 1 | 2008 | 16 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2009 | 826 | 0.020 |
Why?
|
| Abdomen | 1 | 1994 | 1136 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2014 | 747 | 0.020 |
Why?
|
| Papio | 1 | 2010 | 671 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1996 | 1942 | 0.020 |
Why?
|
| Propylene Glycol | 1 | 2008 | 30 | 0.020 |
Why?
|
| Immunoelectrophoresis | 1 | 1988 | 94 | 0.020 |
Why?
|
| Complement Activation | 1 | 2010 | 447 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2010 | 577 | 0.020 |
Why?
|
| Buffers | 1 | 1988 | 143 | 0.020 |
Why?
|
| Horse Diseases | 1 | 1988 | 55 | 0.020 |
Why?
|
| Lysine | 1 | 1993 | 1000 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 2004 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2010 | 13677 | 0.020 |
Why?
|
| Anilides | 1 | 2011 | 413 | 0.020 |
Why?
|
| Osmosis | 1 | 2007 | 103 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 730 | 0.020 |
Why?
|
| Food | 1 | 2012 | 768 | 0.020 |
Why?
|
| Plastics | 1 | 2008 | 119 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2001 | 3713 | 0.020 |
Why?
|
| Portal Vein | 1 | 2010 | 435 | 0.020 |
Why?
|
| Focal Adhesions | 1 | 2007 | 113 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2007 | 510 | 0.020 |
Why?
|
| Cadaver | 1 | 2011 | 1364 | 0.020 |
Why?
|
| Ethidium | 1 | 1986 | 27 | 0.020 |
Why?
|
| Age Factors | 1 | 2024 | 18415 | 0.020 |
Why?
|
| Tendons | 1 | 1991 | 557 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 1988 | 224 | 0.020 |
Why?
|
| Endothelium | 1 | 1989 | 768 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 1960 | 0.020 |
Why?
|
| Elasticity | 1 | 2008 | 657 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 221 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 449 | 0.020 |
Why?
|
| Pyridines | 1 | 1997 | 2894 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 1528 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1989 | 667 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2010 | 1191 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 702 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 864 | 0.010 |
Why?
|
| Shear Strength | 1 | 2005 | 160 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1993 | 1397 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1992 | 8052 | 0.010 |
Why?
|
| Arteries | 1 | 1989 | 1127 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 103 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1997 | 2819 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1990 | 1217 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2022 | 22290 | 0.010 |
Why?
|
| Neutrophil Activation | 1 | 2004 | 180 | 0.010 |
Why?
|
| Methionine | 2 | 1990 | 573 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1997 | 8741 | 0.010 |
Why?
|
| Species Specificity | 1 | 1988 | 2415 | 0.010 |
Why?
|
| Computer-Aided Design | 1 | 2005 | 294 | 0.010 |
Why?
|
| Genetic Linkage | 2 | 1980 | 2342 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 2001 | 1500 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2011 | 4034 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1989 | 1494 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 30009 | 0.010 |
Why?
|
| Ruthenium | 1 | 2002 | 18 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4834 | 0.010 |
Why?
|
| Pedigree | 3 | 1980 | 4539 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2565 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 6340 | 0.010 |
Why?
|
| Research Design | 1 | 1998 | 6209 | 0.010 |
Why?
|
| Ribonuclease H | 1 | 2002 | 52 | 0.010 |
Why?
|
| Fluorometry | 1 | 2001 | 99 | 0.010 |
Why?
|
| Chemical Precipitation | 1 | 2001 | 175 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2001 | 66 | 0.010 |
Why?
|
| Isoelectric Focusing | 1 | 1981 | 149 | 0.010 |
Why?
|
| Centrifugation | 1 | 2001 | 122 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 2001 | 37 | 0.010 |
Why?
|
| Anions | 1 | 2001 | 137 | 0.010 |
Why?
|
| Corticosterone | 1 | 2002 | 301 | 0.010 |
Why?
|
| Mutation | 2 | 2023 | 30237 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 2001 | 174 | 0.010 |
Why?
|
| Ileum | 2 | 1994 | 558 | 0.010 |
Why?
|
| 7-Alkoxycoumarin O-Dealkylase | 1 | 2000 | 2 | 0.010 |
Why?
|
| Phenolsulfonphthalein | 1 | 2000 | 3 | 0.010 |
Why?
|
| Dicumarol | 1 | 2000 | 9 | 0.010 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Complement C5a | 1 | 2000 | 100 | 0.010 |
Why?
|
| Myeloma Proteins | 1 | 1980 | 71 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 1988 | 1072 | 0.010 |
Why?
|
| Computers | 1 | 2003 | 592 | 0.010 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.010 |
Why?
|
| Membranes, Artificial | 1 | 2002 | 367 | 0.010 |
Why?
|
| Aprotinin | 1 | 2000 | 94 | 0.010 |
Why?
|
| Glucuronosyltransferase | 1 | 2000 | 136 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2000 | 147 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2002 | 877 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2000 | 150 | 0.010 |
Why?
|
| Diazepam | 1 | 2000 | 214 | 0.010 |
Why?
|
| Threonine | 1 | 1980 | 273 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4120 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1989 | 1970 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2000 | 174 | 0.010 |
Why?
|
| Globins | 1 | 1999 | 405 | 0.010 |
Why?
|
| Vasodilation | 1 | 2003 | 967 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1992 | 1535 | 0.010 |
Why?
|
| Aged | 3 | 2025 | 171502 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 1989 | 0.010 |
Why?
|
| Capillaries | 1 | 2001 | 755 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2000 | 410 | 0.010 |
Why?
|
| Oxazines | 1 | 2000 | 358 | 0.010 |
Why?
|
| Karyotyping | 1 | 1980 | 1177 | 0.010 |
Why?
|
| Dipeptides | 1 | 1980 | 386 | 0.010 |
Why?
|
| Heart Rate | 1 | 2009 | 4214 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 1998 | 320 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 542 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1999 | 254 | 0.010 |
Why?
|
| Chimera | 1 | 1979 | 454 | 0.010 |
Why?
|
| Membrane Lipids | 1 | 1998 | 252 | 0.010 |
Why?
|
| Biophysics | 1 | 1998 | 379 | 0.010 |
Why?
|
| Robotics | 1 | 2004 | 812 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2001 | 1049 | 0.010 |
Why?
|
| Peroxidase | 1 | 2000 | 610 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 10101 | 0.010 |
Why?
|
| Epithelium | 2 | 1993 | 1607 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 2000 | 751 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 417 | 0.010 |
Why?
|
| Keratins | 1 | 1997 | 499 | 0.010 |
Why?
|
| Pressure | 1 | 1999 | 1172 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1997 | 694 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2001 | 977 | 0.010 |
Why?
|
| Iodine Radioisotopes | 2 | 1989 | 1034 | 0.010 |
Why?
|
| Genes | 1 | 1979 | 1824 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1977 | 828 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2004 | 2059 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5341 | 0.010 |
Why?
|
| Immunity | 1 | 1981 | 1003 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 1997 | 3703 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2000 | 1319 | 0.010 |
Why?
|
| Melanocytes | 1 | 1997 | 509 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 1801 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2009 | 4530 | 0.010 |
Why?
|
| Cephradine | 1 | 1993 | 4 | 0.010 |
Why?
|
| Penicillin V | 1 | 1993 | 18 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1997 | 1080 | 0.010 |
Why?
|
| Diet | 1 | 2011 | 8089 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2001 | 15453 | 0.010 |
Why?
|
| Kidney | 2 | 2002 | 7064 | 0.010 |
Why?
|
| Body Water | 1 | 1993 | 340 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1992 | 209 | 0.010 |
Why?
|
| Gene Products, env | 1 | 1993 | 250 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 1992 | 235 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1991 | 540 | 0.010 |
Why?
|
| Thymidine | 1 | 1990 | 297 | 0.010 |
Why?
|
| Uridine | 1 | 1990 | 135 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 3728 | 0.010 |
Why?
|
| Tritium | 1 | 1990 | 707 | 0.010 |
Why?
|
| Heart | 1 | 2002 | 4446 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1703 | 0.000 |
Why?
|
| Leucine | 1 | 1990 | 547 | 0.000 |
Why?
|
| Infant, Newborn | 2 | 2000 | 26421 | 0.000 |
Why?
|
| Software | 1 | 2002 | 4480 | 0.000 |
Why?
|
| Renal Circulation | 1 | 1988 | 291 | 0.000 |
Why?
|
| Horses | 1 | 1988 | 295 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 4793 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2474 | 0.000 |
Why?
|
| Immune Sera | 2 | 1978 | 605 | 0.000 |
Why?
|
| Synovial Fluid | 1 | 1988 | 393 | 0.000 |
Why?
|
| Cardiac Output | 1 | 1988 | 838 | 0.000 |
Why?
|
| Adrenal Glands | 1 | 1988 | 557 | 0.000 |
Why?
|
| Fertilization in Vitro | 1 | 1993 | 1303 | 0.000 |
Why?
|
| Testis | 1 | 1988 | 783 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 36741 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1992 | 2227 | 0.000 |
Why?
|
| United States | 1 | 1992 | 73039 | 0.000 |
Why?
|
| Aorta, Thoracic | 1 | 1989 | 1112 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1980 | 5196 | 0.000 |
Why?
|
| Neoplasms, Experimental | 1 | 1987 | 1230 | 0.000 |
Why?
|
| Chromatography, Agarose | 1 | 1976 | 29 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1994 | 54924 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1992 | 59626 | 0.000 |
Why?
|
| Genotype | 1 | 1976 | 13045 | 0.000 |
Why?
|